Progenitor Labs

Develops drugs to regenerate specific tissues of the human body in response to injury, disease or aging.

placeLondon, England, United Kingdom calendar_todayFounded 2010 groups1 employees language progenitortherapeutics.com

Registered entities

Innovation

2 patent families (1 granted) — focus: Physics & computing; filing pace dormant. Cited 15 times.

YearFilings
20121
20131
20161
20171

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon